Home  >  News
you can get e-magazine links on WhatsApp.Click here
  US FDA approves Merck’s Keytruda in combo with chemotherapy, with or without bevacizumab to treat patients with persistent, recurrent or metastatic cervical cancer whose tumors express PD-L1,   October 16, 2021
  EMA approves Roche’s Gazyvaro shorter 90-minute infusion time for people with previously treated or untreated follicular lymphoma,   October 16, 2021
  Sanofi Canada receives Health Canada approval for Sarclisa in combo with carfilzomib & dexamethasone for r/r refractory multiple myeloma,   October 14, 2021
  Eli Lilly’s Verzenio in combo with endocrine therapy gets US FDA approval for certain people with HR+ HER2- high risk early breast cancer,   October 14, 2021
  US FDA & EMA accepts Novartis’ sBLA for Beovu to treat diabetic macular edema,   October 14, 2021
  Drug delivery devices poised for big growth in the next few years,   October 13, 2021
  US FDA grants fast tract designation to GenSight Biologics’ optogenetic therapy GS030 to treat Retinitis Pigmentosa,   October 13, 2021
  AUM Biosciences completes $27 mn series A funding round to advance clinical stage pipeline of precision and targeted cancer therapies,   October 13, 2021
  Boehringer Ingelheim awards its first Translational Medicine Award,   October 13, 2021
  Merck commences tender offer to buy Acceleron Pharma,   October 13, 2021
  GSK unveils plan for UK headquarters of new Consumer Healthcare company,   October 12, 2021
  Australian TGA approves BeiGene’s Brukinsa to treat patients with mantle cell lymphoma,   October 12, 2021
  Sandoz completes acquisition of GSK's cephalosporin business,   October 12, 2021
  Chugai seeks Japanese nod for additional indications of antibody cocktail Ronapreve for prophylaxis of Covid-19 & treatment of asymptomatic Covid-19,   October 12, 2021
  Hyloris Pharma expands cardiovascular pipeline by acquiring global rights of Milrinone capsule from the Baker Institute,   October 11, 2021
  US FDA approves Enzyvant’s Rethymic, a one-time regenerative tissue-based therapy for pediatric congenital athymia,   October 11, 2021
  Brii Bio seeks US FDA emergency use authorization for BRII-196/BRII-198 for non-hospitalized Covid-19 patients at high risk of clinical progression to severe disease,   October 11, 2021
  Roche’s anti-amyloid beta antibody gantenerumab gets US FDA Breakthrough Therapy Designation to treat Alzheimer’s disease,   October 11, 2021
  US FDA announces California, Florida, Utah and Wisconsin enter domestic Mutual Reliance agreements with the agency,   October 09, 2021
  Clinigen partners with Humanigen for Lenzilumab Managed Access Program,   October 09, 2021

Copyright © 2016 Saffron Media Pvt. Ltd |